FreeCME

Personalized Therapeutic Options for Parkinson's Disease: 2014 Update

This webcast is jointly sponsored by A. Webb Roberts Center for CME of Baylor Health Care System and MedNet.

This activity is supported in part by an independent education grant from UCB Pharmaceuticals.

Specialty: Neurology

Release date: April 30, 2014

Valid through: April 30, 2015

Target Audience:

This webcast is directed primarily to neurologists and health care professionals involved in the treatment and management of patients with Parkinson's disease. No specific skill or knowledge other than a basic training in neurology is required for successful participation in this activity.

Program Overview:

This webcast is intended to improve care of patients with Parkinson's disease by accelerating adoption of new guidelines and evidence-based practice change. In addition to chemotherapy, this enduring webcast will focus on individualized treatment options. In-depth discussion of novel agents at various stages of clinical development will be given significant focus. This enduring online activity is designed to provide clinical decision-making strategies for integration of novel therapeutic options.

This program consists of 2 continuing education activites.

Module 1 — Ray Dorsey, MD — 0.5 AMA PRA Category 1™ Credit Hours

Module 2 — Daniel E. Kremens, MD — 0.75 AMA PRA Category 1™ Credit Hours